Four days ago, The Guardian reported that there was “excitement among patients and researchers” in the UK as “personalised mRNA vaccines” for cancer entered their phase 3 trial. On Monday, In Your Area published an article about a personalised mRNA skin cancer vaccine that may also be effective against lung, bladder and kidney cancer.
However, patients may be less excited about these “groundbreaking” injections when they read a paper published last week.
On 23 April, a pre-print paper (not yet peer-reviewed) was published in the journal Authorea that reviewed oncogenesis and autoimmunity caused by mRNA injections. It found that repeated mRNA injections reduce immune surveillance for cancer while at the same time inducing autoimmunity.
The paper found that post-vaccination, the subsequent spike protein expression “may lead to a harmful influence on the immune system of vaccinees, and subsequent accelerated development of cancer and autoimmune disease.”
You shouldn’t play God with gene editing. It doesn’t turn out well. It is too complex for humans

